ACM
RXST icon

Atika Capital Management’s RxSight RXST Stock Holding History

Atika Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-354,907
Closed -$3.19M – 108
2025
Q3 		$3.19M Hold
354,907
– – 0.26% 73
2025
Q2 		$4.61M Sell
354,907
-157,866
-31% -$2.37M 0.46% 50
2025
Q1 		$12.9M Buy
512,773
+104,173
+25% +$3.1M 1.82% 19
2024
Q4 		$14M Sell
408,600
-2,000
-0.5% -$90.2K 1.49% 18
2024
Q3 		$20.3M Buy
410,600
+8,000
+2% +$410K 2.08% 12
2024
Q2 		$24.2M Sell
402,600
-11,400
-3% -$651K 2.37% 9
2024
Q1 		$21.4M Sell
414,000
-30,000
-7% -$1.47M 2.1% 11
2023
Q4 		$17.9M Sell
444,000
-65,352
-13% -$1.92M 2.4% 11
2023
Q3 		$14.2M Sell
509,352
-4,648
-0.9% -$139K 1.86% 22
2023
Q2 		$14.8M Buy
+514,000
New +$11.4M 1.48% 20

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Atika Capital Management's RXST Position: Q4 2025 in Review

Atika Capital Management sold out of RxSight (RXST) in Q4 2025, closing a stake of 354,907 shares — an estimated $3.19M sold.

Atika Capital Management first reported a position in RXST in Q2 2023 and held it in 10 quarters. The position peaked at $24.2M in Q2 2024. 163 funds tracked by Wall St. Rank hold RXST as of Q4 2025.

  • Atika Capital Management reported no remaining RxSight position as of Q4 2025 after selling out during the quarter.
  • Atika Capital Management sold 354,907 RxSight shares in Q4 2025, an estimated $3.19M.
  • Atika Capital Management first reported a position in RxSight in Q2 2023 and held it in 10 quarters.
  • Atika Capital Management's RxSight position peaked at $24.2M in Q2 2024.
  • 163 funds tracked by Wall St. Rank held RxSight as of Q4 2025.

Based on Atika Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.